Enviado por ETC Staff el
Bolivia's National Association of Quinoa Producers (ANAPQUI) is asking two professors at Colorado State University to abandon their controversial patent on one of the country's most important food crops - quinoa (Chenopodium quinoa) - a crop that feeds millions throughout the Andes, including many Aymara and Quechua Indigenous People.
Enviado por ETC Staff el
The CGRFA held its 7th regular session in Rome from 15-23 May, 1997. the commission's 154 member countries had 2 tasks: to continue negotiations leading to a legally-binding International Undertaking covering plant genetic resources that could become an agricultural protocol to the Biodiversity Convention, and, to maintain the momentum achieved through last year's Leipzig Conference on Plant Genetic Resources. Most commission members exceeded their own expectations regarding the International Undertaking - but they fell short of the acceptable minimum on the second objectve.
Enviado por ETC Staff el
Commercial development of sweet proteins derived from African plants could be worth millions if new, natural sweeteners can bite into the (US) $2 billion low-calorie sweetener market.(1)
Research on intensely sweet proteins is not new, but recent breakthroughs may improve prospects for commercial development.
Enviado por ETC Staff el
In recent years, the CGIAR ( Consultative Group on International Agricultural Research) has come under fire for a governance structure that far more reflects the orientation of scientists in the North than it does their counterparts in the South. At the time of the CG's second review in 1981, there were slightly more South trustees in the system than North. During the nineties however, the tables have turned, and the North now dominates the roster with most of the trustees and almost all of the key management positions. Since he took over the reins as Chair of the CGIAR in 1994, the World Bank's Ismail Serageldin has fought an uphill battle with the 16 International Agricultural Research Centres (IARCS) that form the CG network in order to increase the role of the South. Many credit Serageldin with limited, but praiseworthy, success.
Enviado por ETC Staff el
It's not whether drug companies need patents to create new drugs - but whether society can survive monopoly control over medical research, according to research undertaken by RAFI (Rural Advancement Foundation International). The world's drug industry represents a health risk and cannot be entrusted with the task of medical research," Pat Mooney, executive director of RAFI insists.
Enviado por ETC Staff el
Will governments opt for a multilateral system of crop germplasm exchange or will they determine to pursue bilateral agreements between countries and companies? RAFI examines Africa's bargaining position, and concludes that bilateral negotiations over crop germplasm will benefit the North, at the expense of food security in the South.
Enviado por ETC Staff el
RAFI's analysis of overlapping agendas for biodiversity, food security and genetic resources in the multilateral arena. The year 1996 was critical for food security, agricultural development, and biodiversity. The fights and fora include: FAO World Food Summit, the Leipzig Conference on Plant Genetic Resources, the Convention on Biological Diversity (CBD) the Consultative Group on International Agricultural Research (CGIAR). A 12 page document.
Enviado por ETC Staff el
RAFI contacted the inventors of the cloned sheep Dolly, confirming that that the worldwide patents on the cloning technology cover all animals, including humans.
Enviado por ETC Staff el
Two trends in industrial agriculture are contributing to the erosion of farmers' rights and lead to bioserfdom: 1) Monsanto's 1996 gene licensing agreement; 2) "Precision farming" and the role it plays in the commodification of information technology and the growing influence of the life industry in farm-level decision-making.
Enviado por ETC Staff el
A Colombian genetics institute has offered to return its collection of thousands of samples of human tissue collected in dozens of Colombian indigenous peoples' communities. Indigenous peoples' representatives, including Colombian Senator Lorenzo Muelas and the OrganizaciÛn Nacional IndÌgena de Colombia (ONIC - National Indigenous Peoples' Organisation of Colombia), are currently negotiating the formal return of control and ownership of the samples, which are housed in a Bogot· human tissue bank.
Enviado por ETC Staff el
If you have a close eye on bioprospecting, you may have heard about the particularly grandiose plans of the International Organisation for Chemical Sciences in Development's (IOCD) Biotic Exploration Fund". The Fund is a major international effort to promote bioprospecting originally proposed by Thomas Eisner, an academic who "conceived and facilitated" the Merck/InBio deal in Costa Rica. IOCD has hired a former Science and Technology Adviser to the World Bank to push the Fund, which is being aggresively promoted to many potential Northern funding agencies.
IOCD, a Belgian-chartered international NGO with a legal identity in the United States, is unabashedly fanatical about the potential for bioprospecting to protect the environment and be a "sustainable source of economic development." In fact, according to IOCD, without bioprospecting, the world's diversity may be doomed: "In comparison with the severity of the global biodiversity crisis, the amount of bioprospecting in developing countries is clearly far too small. Hence, the only appropriate response to the global crisis would be a great expansion of the scale and quality of bioprospecting throughout the developing world."
Enviado por ETC Staff el
Before disclosing the cloning breakthrough, patent applications were filed and research papers prepared for publication. PPL Therapeutics, a small biotechnology company will be assigned the patent. After the cloning announcement, shares of PPL Therapeutics jumped 16% in one day on the London Stock Exchange.
Enviado por ETC Staff el
This map illustrates the transfer of human tissues through third countries. This graphic is part of the Communique on Human Tissue Trade.
Enviado por ETC Staff el
Despite the promise of medical breakthroughs, the utilization of human tissue prompts intense ethical concerns regarding ownership of human biomaterials, eugenics, discrimination and medical confidentiality. A large and growing South to North and North to North movement of human tissue is taking place in an almost total policy and regulatory vacuum.
Enviado por ETC Staff el
Company Estimated 1996 seed sales (US) millions Comment
Pioneer Hi-Bred Intl. (USA) $1,721 Dupont now owns 20% share in Pioneer
Novartis (Switzerland) $991 formerly Ciba Geigy and Sandoz
Limagrain (France) $552 French cooperative; claims to be the world's largest vegetable seed company.
Advanta - joint venture of Zeneca/Van der Have (The Netherlands) $493 Zeneca and Royal VanderHave established joint venture in 1996. The name of their merged company is Advanta
Enviado por ETC Staff el
Just when we thought that the U.S. patent system couldn't possibly operate any more to the advantage of big business, there's a bill before the US Congress that proposes to modernize" the US Patent and Trademark Office by making it a private corporation. (1)
Privatization of the US PTO? This is not a joke. HR 400, "The 21st Century Patent System Improvement Act" is a series of six acts that propose major changes in the US patent system. Backed by powerful interests, the bill is moving quickly through Congress, and a vote is expected in the House of Representatives any day.
Enviado por ETC Staff el
An introduction to intellectual property monopolies. The 70 page booklet produced by IDRC in 1996 is designed as an information and advocacy tool for civil society and policymakers in response to two new, legally binding international agreements: the Convention on Biological Diversity and the World Trade Organization's Trade Related Intellectual Property Agreement (WTO/TRIPs).
Enviado por ETC Staff el
"Biopiracy" -- a term coined by RAFI in 1994 - refers to the use of intellectual property laws to gain exclusive monopoly control over genetic resources that are based on the knowledge and innovation of farmers and indigenous peoples. This issue examines a patent claim on Bolivian quinoa, a US patent on turmeric, and more.
Enviado por ETC Staff el
Protocol on Gene Access Could MUSEum Farmers' Rights & Sanction North's MonoUSE
Enviado por ETC Staff el
After months of indecision and confusing signals, the US National Institutes of Health (NIH) has finally put an end to its internationally-denounced patent on the human cell line of a Hagahai indigenous person from Papua New Guinea. I hope this is the end of what is arguably the most offensive patent ever issued." says Alejandro Argumedo of the Canada-based Indigenous Peoples' Biodiversity Network (IPBN).
Para saber más sobre el Grupo ETC o para contactarnos.